InvestorsHub Logo
Followers 0
Posts 51
Boards Moderated 0
Alias Born 05/02/2006

Re: None

Tuesday, 11/21/2006 1:25:13 PM

Tuesday, November 21, 2006 1:25:13 PM

Post# of 132
Sanguine Corporation CEO Featured in Exclusive Interview With WallSt.net
THURSDAY, OCTOBER 26, 2006 7:00 AM
- PR Newswire

SGNC
0.10 n/a



NEW YORK, Oct 26, 2006 /PRNewswire via COMTEX/ -- On October 24, Dr. Thomas Dress, Chief Executive Officer for Sanguine Corporation (SGNC) updated the investment community in an exclusive interview with www.wallst.net. Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.

To hear the interview in its entirety, visit www.wallst.net , and click on "Interviews." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the respective company's ticker symbol in the Search Archive window.

About Sanguine Corporation:

Sanguine Corporation is a public company based in Pasadena, California, whose primary focus is the development of PHER-O2, a perfluorocarbon (PFC) emulsion with oxygen carrying properties that has immediate applications as an intravenous supplement to red blood cell function. For more information, please visit the company website at www.sanguine-corp.com .

About WallSt.net:

www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive two hundred eighty dollars from Sanguine Corporation for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp .


SOURCE WallStreet Direct, Inc.

Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST


http://www.wallst.net


Copyright (C) 2006 PR Newswire. All rights reserved

invest at your own risk, based on your own due diligence, at your own risk tolerance

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.